Frontiers in Cardiovascular Medicine

FEBRUARY 25, 2025

Research objectiveThis study is based on bioinformatics analysis to explore the co-expressed differentially expressed genes (DEGs) between atrial fibrillation (AF) and chronic kidney disease (CKD), identify the biomarkers for the occurrence and development of the two diseases, investigate the potential connections between AF and CKD, and explore the (..)

Kidney Disease 52

Kidney Disease Atrial Fibrillation Biomarkers Download 52

American College of Cardiology

MARCH 31, 2025

25 in Chicago and simultaneously published in JACC.

Preserved Ejection Fraction 64

Preserved Ejection Fraction Kidney Disease Obesity Heart Failure 64

Science Daily - Heart Disease

JULY 8, 2024

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.

Diabetes 126

Diabetes Kidney Disease Research 126

Science Daily - Heart Disease

FEBRUARY 14, 2025

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

Heart attacks 112

Heart attacks Heart Attack Kidney Disease Heart Failure 112

American Heart News - Heart News

SEPTEMBER 5, 2024

Research Highlights: A new study finds that up to 74% of participants with resistant or difficult-to-control high blood pressure, including those with chronic kidney disease, were able to improve control of their blood pressure within 12 months after.

Blood Pressure 119

Blood Pressure Kidney Disease Research 119

Circulation

JANUARY 27, 2025

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Strokes Stroke 81

Cardiovascular Diabetology

FEBRUARY 14, 2025

People living with diabetes mellitus (DM) and chronic kidney disease (CKD) are at significantly high risk of cardiovascular events (CVEs), however the predictive performance of traditional risk prediction meth.

Kidney Disease 76

Kidney Disease Diabetes Research 76

HCPLive

MAY 25, 2024

Data from ERA 24 builds on previous research examining the effect of SGLT2 inhibitors on hemoglobin levels among patients with chronic kidney disease.

Kidney Disease 105

Kidney Disease Research 105

American Heart News - Heart News

NOVEMBER 11, 2024

Research Highlights: Scientists conducted a simulation study to estimate the impact of cardiovascular-kidney-metabolic (CKM) syndrome on cardiovascular disease (CVD) risk prediction. The study found that adults with chronic kidney disease would have.

Kidney Disease 107

Kidney Disease Heart Disease Cardiovascular Disease Research 107

Cardiovascular Diabetology

MARCH 21, 2025

Mineralocorticoid receptor antagonists (MRAs) are often underutilized in patients with heart failure (HF), particularly those with diabetes and/or chronic kidney disease (CKD). However, the impact of concurren.

Kidney Disease 59

Kidney Disease Heart Failure Diabetes Hospital 59

CardiacWire

MAY 8, 2024

A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2%

Kidney Disease 116

Kidney Disease Obesity Risk Factors Diabetes 116

Cardiovascular Diabetology

APRIL 9, 2024

Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc.

Kidney Disease 64

Kidney Disease Hypertension Public Health Diabetes 64

Cardiovascular Diabetology

MAY 2, 2024

Insulin resistance and chronic kidney disease are both associated with increased coronary artery disease risk. Many formulae estimating glucose disposal rate in type 1 diabetes infer insulin sensitivity from c.

Coronary Artery Disease 124

Coronary Artery Disease Diabetes Kidney Disease Research 124

Cardiovascular Diabetology

MARCH 27, 2025

Its association with diabetic kidney disease (DKD) wo. Cardiovascular Autonomic Neuropathy (CAN) is one of the most devastating complications of Diabetes Mellitus (DM) and presents high morbidity and mortality.

Kidney Disease 52

Kidney Disease Diabetes Research 52

HCPLive

OCTOBER 25, 2024

New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.

Kidney Disease 64

Kidney Disease Diabetes Research 64

Cardiovascular Diabetology

APRIL 24, 2024

This study was designed to assess the associations between emerging cardiometabolic indices—the atherogenic index of plasma (AIP), the stress hyperglycemia ratio (SHR), the triglyceride-glucose (TyG) index, an.

Kidney Disease 98

Kidney Disease Diabetes Research 98

Cardiovascular Diabetology

JUNE 14, 2024

Diabetic kidney disease is an established risk factor for heart failure. However, the impact of incident heart failure on the subsequent risk of renal failure has not been systematically assessed in diabetic p.

Kidney Disease 52

Kidney Disease Heart Failure Diabetes Risk Factors 52

Cardiovascular Diabetology

OCTOBER 8, 2024

Most existing risk equations for predicting/stratifying individual diabetic kidney disease (DKD) risks were developed using relatively dated data from selective and homogeneous trial populations comprising pre.

Kidney Disease 52

Kidney Disease Diabetes Research 52

Cardiovascular Diabetology

JANUARY 2, 2024

The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance and previous studies have confirmed the association of TyG index with incident chronic kidney disease (CKD). However, t.

Kidney Disease 59

Kidney Disease Diabetes Research 59

Cardiovascular Diabetology

JANUARY 8, 2024

Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Myocardial Infarction Kidney Disease Diabetes 105

Cardiovascular Diabetology

OCTOBER 23, 2024

A Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) formula not including a Black race coefficient has been recently developed and is now recommended in the US. The new (2021) equation was shown to.

Kidney Disease 52

Kidney Disease Diabetes Research 52

Circulation

MARCH 9, 2025

Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors. Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025.

Kidney Disease 83

Kidney Disease Biomarkers Heart Failure Risk Factors 83

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Coronary Artery Disease Journal

JUNE 18, 2024

Background Advanced chronic kidney disease (ACKD) is common in patients undergoing percutaneous coronary intervention (PCI) and is associated with adverse outcomes. These patients are often excluded from revascularization studies. The goal of this study was to evaluate the impact of ACKD in patients undergoing PCI.

Kidney Disease 40

Kidney Disease Inpatient Outcomes Research 40

European Journal of Heart Failure

JANUARY 17, 2025

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: a FIDELITY analysis. a If patients were receiving both types of diuretics at baseline, they were included in both subgroups.

Kidney Disease 40

Kidney Disease Diabetes Myocardial Infarction Heart Failure 40

HCPLive

MAY 2, 2024

This month in review highlights top coverage of the latest news in nephrology, ranging from new clinical trial data in IgAN to research about kidney disease management.

Kidney Disease 59

Kidney Disease Research 59

European Journal of Heart Failure

FEBRUARY 5, 2025

Meta-analysis on the main outcomes of angiotensin receptorneprilysin inhibitor (ARNI) in heart failure (HF) patients with end-stage kidney disease (ESKD) on dialysis. However, the evidence on the benefits of ARNI in HF patients with end-stage kidney disease (ESKD) undergoing dialysis is limited.

Kidney Disease 49

Kidney Disease Heart Failure Preserved Ejection Fraction Blood Pressure 49

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

IntroductionSystemic inflammation is recognised as a critical driver of atherosclerotic cardiovascular disease (ASCVD), especially in patients with comorbid chronic kidney disease (CKD).

Kidney Disease 52

Kidney Disease Cardiovascular Disease Cholesterol Obesity 52

Circulation

NOVEMBER 11, 2024

Background:There have been several studies postulating the association between Mitral valve stenosis (MS) and Chronic Kidney Disease (CKD).

Kidney Disease 40

Kidney Disease Bicuspid/Mitral Stenosis Document 40

Frontiers in Cardiovascular Medicine

APRIL 4, 2024

Hypertension is a leading cause of morbidity and mortality worldwide and poses a major risk factor for cardiovascular diseases and chronic kidney disease.

Blood Pressure 98

Blood Pressure Kidney Disease Hypertension Risk Factors 98

Cardiovascular Diabetology

DECEMBER 12, 2023

In the last years, the classical pattern of diabetic kidney disease (DKD) has been partially overcome, because of the uncovering of a new DKD phenotype with significant renal dysfunction without presence of al.

Kidney Disease 40

Kidney Disease Diabetes Research 40

DAIC

JULY 30, 2024

This study by Fujita Health University researchers revealed that kidney function, considered in terms of estimated glomerular filtration rate (eGFR), can be used as a predictor for SCD in patients with congestive heart failure. During the follow-up period, 198 of these patients suffered from SCD.

Sudden Cardiac Death 111

Sudden Cardiac Death Heart Failure Risk Factors Kidney Disease 111

Cardiovascular Diabetology

AUGUST 6, 2024

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

Cardiovascular Diabetology

JULY 3, 2024

Despite improved glycemic treatment, the impact of glycation on pathological consequences may persist and contribute to adverse clinical outcomes in diabetes. In the present study we.

Diabetes 64

Diabetes Kidney Disease Outcomes Research 64

DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. Researchers tracked outcomes for a median of just under 18 months. The study’s primary composite endpoint occurred in 8.2% of those who received empagliflozin and 9.1%

Heart attacks 98

Heart attacks Heart Attack Heart Failure Outpatient 98

Cardiovascular Diabetology

MARCH 28, 2025

The Cardiovascular-Kidney-Metabolic (CKM) syndrome underscores the complex interactions among metabolic disorders, kidney disease, and cardiovascular conditions. Insulin resistance (IR) and inflammation are cr.

Kidney Disease 59

Kidney Disease Research 59

DAIC

APRIL 30, 2024

The drug, dapagliflozin, was initially approved for the treatment of Type 2 diabetes, but it since has been shown to reduce the risk of hospitalization for heart failure and death in patients with serious health problems that include heart and chronic kidney disease and heightened cardiovascular risk.

Heart Failure 105

Heart Failure Hospital Research COVID-19 105